Sowell Financial Services LLC Ligand Pharmaceuticals Inc Transaction History

Sowell Financial Services LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 13, 2021	SELL	$80.55 - $106.05 $886 - $1,166	-11 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$89.56 - $126.72 $626 - $887	-7 Reduced 38.89%	11 $1,000
Q2 2020 Aug 13, 2020	SELL	$68.28 - $123.65 $3,687 - $6,677	-54 Reduced 75.0%	18 $2,000
Q1 2020 May 12, 2020	SELL	$63.37 - $107.88 $4,245 - $7,227	-67 Reduced 48.2%	72 $5,000
Q4 2019 Feb 07, 2020	SELL	$96.94 - $113.59 $290 - $340	-3 Reduced 2.11%	139 $14,000
Q3 2019 Nov 14, 2019	BUY	$86.25 - $120.16 $12,247 - $17,062	142 New	142 $14,000

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.88B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.